127 results
Page 3 of 7
8-K
EX-99.1
3d45 cn1al
18 Nov 20
AbbVie Announces Expiration and Final Results of Registered Exchange Offers
5:16pm
8-K
EX-99.1
eba7liop
30 Oct 20
AbbVie Reports Third-Quarter 2020 Financial Results
7:52am
8-K
EX-99.1
7dtbdph5opw2q5w3
19 Oct 20
AbbVie Announces Commencement of Registered Exchange Offers
9:13am
8-K
EX-99.1
myjj30uv69uf962g9nwl
31 Jul 20
AbbVie Reports Second-Quarter 2020 Financial Results
8:41am
8-K
EX-99.1
r9t y1rl2cjxnl
8 May 20
AbbVie Completes Transformative Acquisition of Allergan
4:31pm
8-K
EX-99.1
bucla54aoxcl6 wxl2e2
6 May 20
AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie’s Acquisition of Allergan
12:00am
8-K
EX-99.1
3fk88a lj0gk5ohxrna1
1 May 20
AbbVie Reports First-Quarter 2020 Financial Results
7:44am
8-K
EX-99.1
ctgx1gjl
7 Feb 20
AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results
7:48am
8-K
EX-99.1
b6gkhj
13 Nov 19
AbbVie Prices $30 Billion of Senior Unsecured Notes
4:43pm
8-K
EX-99.2
191nykc16glpub
6 Nov 19
Regulation FD Disclosure
3:30pm
8-K
EX-99.1
om4r3j1ql0z5i4
1 Nov 19
AbbVie Reports Third-Quarter 2019 Financial Results
7:50am
8-K
EX-99.1
kfq7x tlkjjft
26 Jul 19
AbbVie Reports Second-Quarter 2019 Financial Results
7:44am